French Company Develops Promising Injectable Ivermectin

New Post Public Reply Private Reply Replies (0) Message Board
Rusty Bhawks #75920
250
French Company Develops Promising Injectable Ivermectin Treatment, But There’s a Catch
January 14, 2022

Anything that has the Bill Gates stamp of approval is instantly suspicious, and the Bill and Melinda Gates Foundation is behind the company making the Ivermectin injections.

Ivermectin has been shown by numerous studies to be effective against the coronavirus.

The fact that it’s being suppressed by our own government and panned by mainstream media tells me there’s something beneficial about the drug.

They wouldn’t call it a “horse dewormer” unless they believed it was either truly dangerous or so effective that it could derail their universal vaccine objectives.

We know it’s not the former because the government has been recommending Ivermectin for years to people coming to America from Africa.

They can’t say it’s dangerous to some but recommend it to others unless there’s a different agenda at play.

There is good reason to have hope for a new way to deliver IVM to millions of people to fight COVID variants. It offers a very sound alternative to vaccines.

With all of the considerable controversy about using IVM for treating and preventing COVID, something has slipped the attention of its supporters and critics. A relatively small French company has spent the past year or more developing an injectable product of IVM for prophylactic use and have it last in the body for months.

It has successfully completed a safety study for relatively high doses of IVM over long periods. The company tested IVM taken daily in oral form to simulate the continuous release of the active substance by a long-acting injectable. It found the results fully supportive of their injectable approach.

If the company is able to get the commercial product into the market and, if needed, get regulatory approval, their product could compete against COVID vaccines and avoid the need for the new Pfizer and Merck antiviral treatment drugs.

One can imagine that this innovative product could be just like annual flu vaccines in how it is administered to large numbers of people in a multitude of places, including medical offices, drug stores and supermarket pharmacies. And it would be wonderful if medical insurance covered it like it does for flu shots.

Here is some more information about this venture: The company is MedinCell. It has received financial support from the French government. It was started with the help of the Bill and Melinda Gates Foundation.

At its website it is possible to download a March 2021 lengthy and detailed assessment and review of IVM focusing on its history of intense global use and safety. The title is Medical Safety of Ivermectin. Here are the conclusions:

“Hundreds of millions of human subjects have been treated with ivermectin for curative or prophylactic purposes worldwide over the last 3 decades. The reference list of this report demonstrates that a large body of data is available, which allows for a detailed analysis of ivermectin medical safety.

Undoubtedly, uncertainties remain regarding ivermectin pharmacological effects and mechanisms of action, but when removed, this is not anticipated to alter the main conclusions of this report in any significant way as they rely on an extensive and consistent body of medical publications.

Taking into account all the above, the author of the present analysis of the available medical data concludes that the safety profile of ivermectin has so far been excellent in the majority of treated human patients so that ivermectin human toxicity cannot be claimed to be a serious cause for concern.”

https://truthbasedmedia.com/2022/01/14/french...s-a-catch/

Clinical Trial Conducted by MedinCell Confirms the Safety of Continuous Administration of ivermectin

https://www.businesswire.com/news/home/202104...-of-Contin
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LITEON's Q3 Surge: Record Profits, AI Focus Amplified

Updated Category News Views 79

LITEON Smashes Q3 Records, Financials Speak Volumes You don't find numbers like these under every rock. LITEON Technology is rolling in it after clinching third quarter revenues of NT$57.4 billion, marking a significant 9% growth compared to the previous quarter and a whopping 28% surge year-over-year. That's the kind of financial football that gets investors holding onto...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 72

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Polypropylene Takes a Quantum Leap with Dyeability Boost

Updated Category News Views 53

Revolutionizing Polypropylene’s Dyeability Problem There's a new kid on the block in the textile world, and it's turning heads for good reason. Picture this: polypropylene, which typically struggled with dyeability, now boasting a PET-like finish, thanks to a groundbreaking collaboration between Newlight Technologies and Prime Polymer. They've taken polypropylene and...

Continue Reading
D-Wave Faces Securities Fraud Class Action: Details Inside

Updated Category News Views 41

D-Wave Quantum Inc. in Hot Water Well folks, looks like D-Wave Quantum Inc. (NASDAQ: QBTS) is knee-deep in a securities fraud class action lawsuit. This ain't just another day in the quantum computing trenches. We've got Kessler Topaz Meltzer & Check, LLP, a big player in securities litigation, rallying the troops here—a clear sign that this case is packing some hefty...

Continue Reading
Fluence Energy Faces Class Action with 34.63% Stock Drop

Updated Category News Views 56

Rough Times for Fluence Energy Shareholders Fluence Energy, Inc. (NASDAQ:FLNC) has been treading choppy waters with a stock plunge of 34.63%, leaving investors gasping for air. This isn't your typical market jitters—it's tied up with a securities fraud class action, which seems to have taken the wind right out of their sails. In the twisted world of energy stocks, any...

Continue Reading
Navigating New Home Builds: Tucson’s Precise Timelines

Updated Category News Views 69

Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...

Continue Reading
Gutiérrez Honored with Enrique V. Iglesias Award

Updated Category News Views 5

Gutiérrez Recognized for Civic and Business Impact Alright, folks, here's a scenario to chew on: Dionisio Gutiérrez, a name that's likely resonated in business and civic corridors for a while, is about to add another feather to his cap. This November 4, Gutiérrez will bask in the limelight as King Felipe VI of Spain hands him the 11th Enrique V. Iglesias Award. It's...

Continue Reading
Maya Mobile Wins Best Global Roaming Services 2026

Updated Category News Views 40

Travelers Speak: Maya Tops Global Roaming It's not every day that you see the travel community collectively high-five a company, but that's precisely what happened with Maya Mobile. These folks just snagged the Best Global Roaming Services title at the TripZilla Excellence Awards 2026, and it's not just fluff—it's voted by travelers. This ain't your typical pat on the...

Continue Reading
Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 66

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
Good Springs Earns Spot on Inc.'s 2026 Founder List

Updated Category News Views 31

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Continue Reading

Top 5 Most Recently Viewed Articles

Porton Advanced Gains Class C License for CGT Scale-Up

Updated Category News Views 46

Milestone for Porton Advanced: Class C License Secured Look who's leveling up in the CGT game! No small feat here—Porton Advanced, having just snagged a Drug Manufacturing License Class C from the NMPA, can now waltz its way from development into commercial manufacturing. This makes the company an even bigger player in the Contract Development and Manufacturing...

Continue Reading
Benson Boone Celebrated with BMI Champion Award at 2025 Event

Updated Category News Views 455

Benson Boone Honored at the BMI Pop Awards Benson Boone, a GRAMMY-nominated singer-songwriter, is set to receive the esteemed BMI Champion Award during the upcoming BMI Pop Awards. This significant recognition highlights not only Boone's impact on the music industry but also his dedication to artistry. A Night of Celebration The BMI Pop Awards will feature a gala event...

Continue Reading
ECARX Reports Impressive Growth in First Quarter Financials

Updated Category News Views 244

ECARX Holdings Inc. Reports Impressive First Quarter Growth ECARX Holdings Inc. (Nasdaq: ECX), a key player in the global mobility tech sector, has unveiled its unaudited financial results for the first quarter of 2025. The company continues to build on the momentum achieved throughout the previous year, demonstrating a robust performance amidst dynamic market conditions....

Continue Reading
Chadwick Westlake to Present at Scotiabank Financials Summit

Updated Category News Views 154

Chadwick Westlake to Present at Scotiabank's Financial Services Summit Chadwick Westlake, the esteemed President and CEO of EQB Inc., which encompasses Equitable Bank, Canada's premier Challenger Bank™, is set to speak at the Scotiabank's 26th Annual Financial Services Summit. This event is scheduled for September 3 and is bound to attract significant interest from...

Continue Reading
Groundbreaking SPECT Imaging Study Enhances Prostate Cancer Care

Updated Category News Views 173

Innovative Approach to Prostate Cancer Imaging Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX) and the Oncidium foundation have recently made a significant advancement in prostate cancer imaging with the publication of results from their NOBLE Registry study. This collaborative effort aims to enhance equity in access to state-of-the-art prostate cancer imaging...

Continue Reading